Stay updated on Inhaled Imatinib for PAH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.

Latest updates to the Inhaled Imatinib for PAH Clinical Trial page
- Check4 days agoChange DetectedThere are no recorded additions or deletions in the provided changes data for this page. This indicates that, within the supplied dataset, no textual updates were captured.SummaryDifference0.0%

- Check11 days agoChange DetectedThe study record now shows Revision: v3.6.4, replacing the previous v3.6.3. This reflects a newer version of the page's documentation.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNo textual changes were captured for the page, so the content appears unchanged based on the available data.SummaryDifference0.0%

- Check33 days agoChange DetectedA new publication reference was added to the Publications section, listing authors and the citation for a Phase 2b trial of inhaled imatinib for pulmonary arterial hypertension.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page revision label at the bottom was updated from v3.6.0 to v3.6.3, reflecting a newer version of the page. This update does not alter the displayed study details or interactions.SummaryDifference0.1%

- Check54 days agoChange DetectedRecruitment status updated to no longer look for participants, new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the page's heading formatting and revision tag were updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Inhaled Imatinib for PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.